A detailed history of Ubs Group Ag transactions in Daxor Corp stock. As of the latest transaction made, Ubs Group Ag holds 1,236 shares of DXR stock, worth $10,320. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,236
Previous 4,153 70.24%
Holding current value
$10,320
Previous $38,000 73.68%
% of portfolio
0.0%
Previous 0.0%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$7.86 - $9.7 $22,927 - $28,294
-2,917 Reduced 70.24%
1,236 $10,000
Q2 2024

Aug 13, 2024

BUY
$0.0 - $9.94 $0 - $29,750
2,993 Added 258.02%
4,153 $38,000
Q1 2024

May 13, 2024

BUY
$7.19 - $10.03 $8,340 - $11,634
1,160 New
1,160 $10,000
Q3 2023

Nov 09, 2023

SELL
$9.03 - $10.15 $20,904 - $23,497
-2,315 Reduced 94.53%
134 $1,000
Q2 2023

Aug 11, 2023

BUY
$9.51 - $13.03 $23,289 - $31,910
2,449 New
2,449 $23,000
Q3 2022

Nov 10, 2022

SELL
$12.1 - $14.23 $1,258 - $1,479
-104 Reduced 11.18%
826 $11,000
Q2 2022

Aug 10, 2022

BUY
$10.62 - $13.21 $796 - $990
75 Added 8.77%
930 $12,000
Q1 2022

May 16, 2022

BUY
$10.51 - $11.52 $2,186 - $2,396
208 Added 32.15%
855 $9,000
Q4 2021

Feb 14, 2022

BUY
$10.59 - $11.5 $4,553 - $4,945
430 Added 198.16%
647 $7,000
Q3 2021

Nov 15, 2021

SELL
$8.77 - $12.05 $6,279 - $8,627
-716 Reduced 76.74%
217 $3,000
Q2 2021

Aug 13, 2021

BUY
$8.9 - $14.15 $4,441 - $7,060
499 Added 114.98%
933 $10,000
Q1 2021

May 12, 2021

SELL
$11.02 - $13.86 $9,653 - $12,141
-876 Reduced 66.87%
434 $5,000
Q4 2020

Feb 11, 2021

BUY
$12.15 - $15.77 $6,791 - $8,815
559 Added 74.43%
1,310 $16,000
Q3 2020

Nov 12, 2020

BUY
$14.66 - $23.78 $11,009 - $17,858
751 New
751 $12,000
Q1 2020

May 01, 2020

SELL
$8.6 - $14.25 $9,933 - $16,458
-1,155 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$8.94 - $9.93 $10,325 - $11,469
1,155 New
1,155 $11,000
Q2 2019

Aug 14, 2019

SELL
$7.5 - $11.61 $10,275 - $15,905
-1,370 Closed
0 $0
Q1 2019

May 14, 2019

BUY
$9.11 - $19.52 $12,480 - $26,742
1,370 New
1,370 $15,000
Q4 2018

Feb 14, 2019

SELL
$4.7 - $9.55 $13,667 - $27,771
-2,908 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$4.3 - $6.64 $3,822 - $5,902
889 Added 44.03%
2,908 $15,000
Q2 2018

Aug 14, 2018

BUY
$6.12 - $9.82 $10,563 - $16,949
1,726 Added 589.08%
2,019 $13,000
Q1 2018

May 15, 2018

SELL
$3.52 - $13.89 $8,000 - $31,571
-2,273 Reduced 88.58%
293 $3,000
Q4 2017

Feb 14, 2018

SELL
$4.05 - $5.5 $20 - $27
-5 Reduced 0.19%
2,566 $12,000
Q3 2017

Nov 14, 2017

BUY
$5.06 - $6.2 $13,009 - $15,940
2,571
2,571 $13,000

Others Institutions Holding DXR

About DAXOR CORP


  • Ticker DXR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 4,041,670
  • Market Cap $33.7M
  • Description
  • Daxor Corporation, a medical device company, provides blood volume measurement technology focused on blood volume testing. The company develops and markets BVA-100 Blood Volume Analyzer, a diagnostic blood test to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms for used i...
More about DXR
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.